LOGOMIX INC.
Logomix Inc is a mammalian cellular genome architect startup. Logomix proprietary platform, Geno-Writing™, technology integrates large-scale (Mb) human genome-writing technologies and providing genetically architected versatile human cells and/or downsized cells and microbes for drug development and cell & gene therapy area. Majority of the cell engineering companies are currently focused on optimization of gene clusters by automatic high throughput system however, Logomix’s Geno-Writing�... � provides the required tools for dealing with mammalian or complex genomes. Logomix works with partners by providing new biology-based solutions to co-create business and social values on Geno-Writing™ platform Current Focus Area includes: 1. Human Health & Therapeutics 2. Biomaterials & Chemicals 3. Agriculture & Environment Logomix has 11 ongoing collaborative research partnerships. Currently Logomix is specifically looking for industry partners to address unmet needs in neurodegenerative disease areas.
LOGOMIX INC.
Social Links:
Industry:
Biotechnology
Founded:
2019-07-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.logomixgenomics.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Apps For Business Google Google Cloud Google DNS
Current Employees Featured
Official Site Inspections
http://www.logomixgenomics.com Semrush global rank: 2.48 M Semrush visits lastest month: 7.12 K
- Host name: 208.122.194.35.bc.googleusercontent.com
- IP address: 35.194.122.208
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Logomix Inc."
Logomix EN
Logomix is a platform for designing, building, and optimizing biological systems using advanced synthetic biology tools.See details»
Logomix - LinkedIn
Logomix is a synthetic biology company, reshaping the landscape of human genome engineering. Its Geno-Writing™ platform enables precise engineering …See details»
Logomix - Crunchbase Company Profile & Funding
5,849 Number of Organizations • $54.2B Total Funding Amount • 3,697 Number of Investors. Track . Tokyo Startups Founded in 2019 . 171 Number of Organizations • $917.4M Total …See details»
Logomix 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Logomix. Use the PitchBook Platform to explore the full profile.See details»
Logomix - Overview, News & Similar companies | ZoomInfo.com
Who is Logomix. Information empowers recycling of genomic resources for well-being and healthy ecosystem for all lives on the earth. Logomix is working at the inte rsection of biology and …See details»
Logomix, Inc.｜J-Startup
Logomix is a synthetic biology company, reshaping the landscape of human genome engineering. Its Geno-Writing™ platform enables precise engineering of Mb-scale genomic sequences …See details»
Logomix - Company Profile - Tracxn
Feb 19, 2025 Logomix - Provider of genome engineering platform to create artificial cells. Raised a total funding of $3.79M over 1 round from 6 investors. Founded by Taiki Ishikura and …See details»
Logomix Inc. - VentureRadar
"Logomix is currently creating various versions of artificial cells by its proprietary genome engineering platform Geno-Writing™ to drive revolution in Pharmaceutical industry for drug …See details»
Logomix | NEDO - 国立研究開発法人新エネルギー・産業 ...
Nov 8, 2024 Program name. Deep-Tech Startups Support Program. Research theme. Commercialization of synthetic biology platform. Business Plan. Construction of industrial …See details»
Logomix, Inc. - Viva Technology
Logomix’s technology is like 3D printing of DNA. With its technology, Logomix develops artificial cells ranging from microbe to human cells based on its pioneering genome engineering …See details»
Logomix | LinkedIn
Logomix | 320 followers on LinkedIn. Logomix maximizes the potential of cells by our Mb-scale and ultra-accurate genome engineering. | Logomix is a pioneering synthetic biology company. …See details»
SynBioBeta
Logomix is a large-scale genome writing startup, engineering mammalian genome for industrial customers. We are currently helping biopharma model novel diseases and identify new drug …See details»
Company
Logomix is currently creating various versions of artificial cells by its proprietary genome engineering platform Geno-Writing™ to drive revolution in Pharmaceutical industry for drug …See details»
株式会社Logomix | InfoBase
株式会社Logomix. 会社概要. ゲノム大規模構築技術プラットフォーム「Geno-Writing」を展開する合成生物スタートアップです。See details»
Logomixの会社情報 - Wantedly
Logomixの魅力を伝えるコンテンツと、住所や代表・従業員などの会社情報です。Logomixは、ゲノム大規模構築技術Geno-Writing™※をコア技術とする、2019年創業の東京工業大学発バ …See details»
Logomix Closes $3.9M USD in Oversubscribed Seed Funding to
For over two decades Sand Hill Angels has worked openly and collaboratively with venture capital funds, other angel organizations, and the Bay Area ecosystem that fosters the growth of …See details»
Logomix Inc | Startup Spotlight - Informa Connect
Sep 13, 2023 Logomix’s core competence is Geno-Writing™ platform: a collective knowledge and technologies that enable Mb-scale design and re-construction of human and the other …See details»
Logomix Inc. Starts Joint Research of Sustainable Amino Acid …
Apr 8, 2023 Logomix Inc. (“Logomix”), a start-up company with proprietary genome engineering platform, has concluded a joint research and development agreement with Ajinomoto Co., Inc. …See details»
Logomix JP
Logomixは、世界でも数少ない合成生物ベンチャーです。バクテリア、酵母、動物培養細胞、ヒト幹細胞など様々な生物種の細胞や細胞システムを機能改変しています。ゲノム大規模構築 …See details»
株式会社Logomix - スピーダ スタートアップ情報リサーチ
東工大生命理工学院の技術をベースとしたゲノム構築技術プラットフォームを展開。 産業に有用な細胞を創製するためのゲノム大規模構築技術プラットフォーム「Geno-Writing」の開発・ …See details»